7,778 press releases indexed under healthcare.
Veteran eyecare media finance executive joins the C-suite as the company continues its growth trajectory SAN DIEGO, Sept. 14, 2026 /PRNewswire-PRWeb/ -- Eyes On Eyecare (Eyes On), the #1 provider of clinical and career education for optometrists and ophthalmologists, today announced that...
(PR-inside.com) Double board-certified plastic surgeon adds a hospital-based surgical option for patients whose medical circumstances call for one. PALM BEACH GARDENS, FL / ACCESS Newswire / September 14, 2026 / Dr. Thomas Pane , a double board-certified plastic surgeon practicing in Palm Beach Gardens, has obtained hospital privileges at Holy Cross in Fort Lauderdale. The privileges allow him to perform procedures in a hospital setting when a patient's individual circumstances or medical needs make a hospital more appropriate than an office-based surgical facility or an ambulatory surgery center. The privileges add to the settings already available to Dr. Pane. He performs procedures at ..
Care Transformation Studio today announced a strategic partnership with the Switzerland-based International Society for Telemedicine and eHealth (ISfTeH). This collaboration will provide healthcare organizations, government agencies, and funding institutions with streamlined access to...
Double board-certified plastic surgeon adds a hospital-based surgical option for patients whose medical circumstances call for one.
The 2025 IDEA Fitness Leader of the Year and MSN's #1 Top Health Voice of 2026 joins Glo as its September Featured Guest Teacher HONOLULU, Sept. 14, 2026 /PRNewswire/ -- Dr. Desi Bartlett, Ed.D., founder of The BodyMind Workout™, today announced a new partnership with Glo, the premier...
Ambassador Deborah Birx Announces New Data-Driven Framework Evaluating 16,239 Hospitals Across 65 Countries NEW YORK, Sept. 14, 2026 /PRNewswire/ -- At today's 15TH annual C3 US NYC Davos of Healthcare™ Summit, held alongside the United Nations General Assembly, Davos Healthcare™...
Working With Clients From All Walks of Life, From Fortune 500 Companies to Respected Experts and Global Brands, VEW Media Has Spent 25 Years Finding and Telling Stories That Matter NORTH ATTLEBORO, MA - September 14, 2026 ( NEWMEDIAWIRE ) - VEW Media, the PR agency that has been helping clients get ViEWed globally since 2001, is celebrating its 25 year of business. Over the past quarter-century, VEW Media has represented an extraordinarily diverse roster of clients, including consumer brands, authors, physicians, technology innovators, and Fortune 500 companies, helping each turn what makes them distinctive into stories that resonate with national, international, and industry media. It is celebrating its 25th anniversary in September 2026. Since opening in 2001, the agency has helped compa
Independent Evaluation Supports GEO-MVA Pivotal Phase 3 Program Advances GeoVax’s Strategy to Expand and Diversify MVA Vaccine Supply ATLANTA, GA - September 14, 2026 ( NEWMEDIAWIRE ) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing vaccines and immunotherapies against high consequence infectious diseases and solid tumor cancers, today announced that it has entered into a Memorandum of Agreement with the Coalition for Epidemic Preparedness Innovations (CEPI) providing GeoVax access to clinical trial sample testing services through the CEPI Centralised Laboratory Network in support of its planned pivotal GEO-MVA Phase 3 immune-bridging study. The agreement represents an important step in the continued development of GEO-MVA, GeoVax’s MVA-based vaccine ca
(PR-inside.com) SAN DIEGO, CA / ACCESS Newswire / September 14, 2026 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company") a clinical-stage biotechnology company developing novel neuroplastogenic therapies beyond mood disorders, with an initial focus on CRPS (Complex Regional Pain Syndrome), today announced that Richard Langford, Chief Medical Officer of Cy Biopharma, has been selected to present in person at the U.S. Food and Drug Administration's ("FDA") public hearing, "Considerations for Potential Future Therapeutic Use of Psychedelic Drugs," being held today, Monday, September 14, 2026 at the FDA's White Oak Campus in Silver Spring, Maryland. Dr. Langford is among a limited group ..
New data show 97% opioid abstinence rates among long-term patients as statewide overdose deaths begin to decline. HELENA, Mont., Sept. 14, 2026 /PRNewswire-PRWeb/ -- Ideal Option, a national leader in outpatient medication-assisted treatment (MAT) for addiction to opioids, stimulants and...
Dr Charles Garrison, an experienced pathologist, biotechnology entrepreneur, and life sciences investor will advise MVT on scientific and medical development as new Scientific Advisory Board member. [PR.com]